These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin. Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448 [TBL] [Abstract][Full Text] [Related]
5. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis. Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082 [TBL] [Abstract][Full Text] [Related]
6. Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group. J Thorac Cardiovasc Surg; 1981 Nov; 82(5):649-57. PubMed ID: 7029149 [TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
8. Local BCG-immunotherapy in bladder cancer patients. Immunological follow-up studies. Seyfarth M; Hudemann B; Nizze H; Riedel H; Werner H Arch Geschwulstforsch; 1982; 52(1):63-6. PubMed ID: 7082133 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits. Uyl-de Groot CA; Vermorken JB; Hanna MG; Verboom P; Groot MT; Bonsel GJ; Meijer CJ; Pinedo HM Vaccine; 2005 Mar; 23(17-18):2379-87. PubMed ID: 15755632 [TBL] [Abstract][Full Text] [Related]
11. [Study of delayed hypersensitivity to tuberculin in 130 cancerous adults. Effects of BCG]. Israel L; Mawas C; Bouvrain A; Mannoni P; Sors C Pathol Biol; 1967; 15(11):597-601. PubMed ID: 4860736 [No Abstract] [Full Text] [Related]
12. Intralesional injection of BCG using the fibreoptic bronchoscope in the treatment of bronchogenic carcinoma. Millar JW; Hunter AM; Wightman AJ; Horne NW Eur J Respir Dis; 1980 Jun; 61(3):162-6. PubMed ID: 7439279 [TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up. Järvinen R; Kaasinen E; Sankila A; Rintala E; Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154 [TBL] [Abstract][Full Text] [Related]
14. The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin. Bilen CY; Inci K; Erkan I; Ozen H J Urol; 2003 May; 169(5):1702-5. PubMed ID: 12686812 [TBL] [Abstract][Full Text] [Related]
15. Non-specific immunostimulation in bronchogenic cancer. Israel L Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224 [No Abstract] [Full Text] [Related]
16. Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial. Matthay RA; Mahler DA; Beck GJ; Loke J; Baue AE; Carter DC; Mitchell MS Cancer Res; 1986 Nov; 46(11):5963-8. PubMed ID: 3530442 [TBL] [Abstract][Full Text] [Related]
17. [Surgery and adjuvant therapy of non-small cell lung cancer]. Watanabe Y; Yamada T; Ichihashi T; Hashizume Y; Iwa T Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1534-46. PubMed ID: 3524465 [TBL] [Abstract][Full Text] [Related]
18. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group. Agarwala SS; Neuberg D; Park Y; Kirkwood JM Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858 [TBL] [Abstract][Full Text] [Related]
19. Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study). Giaccone G; Debruyne C; Felip E; Chapman PB; Grant SC; Millward M; Thiberville L; D'addario G; Coens C; Rome LS; Zatloukal P; Masso O; Legrand C J Clin Oncol; 2005 Oct; 23(28):6854-64. PubMed ID: 16192577 [TBL] [Abstract][Full Text] [Related]